Table of contents




Botulism is a rare, life-threatening disease caused by the neurotoxin produced by the bacterium Clostridium botulinum.
Botulism is caused by the anaerobic, Gram-positive bacterium Clostridium botulinum and, rarely, by related species (Clostridium baratii and Clostridium butyricum). The botulinum neurotoxin inhibits acetylcholine release at the neuromuscular junction, leading to muscle paralysis.
In 2019, the CDC has reported 219 cases of botulism in the US.
Disease course
Clinically, botulism presents as a flaccid descending paralysis that begins with cranial nerve palsies and might progress to extremity weakness and respiratory failure. Early symptoms include blurred vision, diplopia, difficulty in focusing, ptosis, facial weakness, dysphagia, dysphonia, and dysarthria.
Prognosis and risk of recurrence
The prognosis of botulism is generally good with appropriate medical care, which includes supportive care, intubation, mechanical ventilation when necessary, and administration of botulinum antitoxin.


Key sources

The following summarized guidelines for the evaluation and management of botulism are prepared by our editorial team based on guidelines from the Center for Disease Control (CDC 2021). ...
Show more

Screening and diagnosis

Differential diagnosis: as per CDC 2021 guidelines, suspect botulism in patients with suspected myasthenia gravis or Guillain-Barré syndrome and in patients with unexplained symmetric cranial nerve palsies, with or without paresis of other muscles.
Create free account

Diagnostic investigations

History and physical examination
As per CDC 2021 guidelines:
Elicit history of possible exposures to well-described sources of botulinum toxin, while keeping in mind that the absence of such exposures does not exclude the possibility of botulism.
Perform thorough, serial neurologic examinations to detect neurologic deficits of botulism and assess their progression.

More topics in this section

  • Laboratory testing

  • Electrodiagnostic studies

Medical management

Contacting local or state health department: as per CDC 2021 guidelines, contact the local or state health department's emergency on-call staff immediately when botulism is suspected to arrange an emergency expert clinical consultation and, when indicated, request botulinum antitoxin.

More topics in this section

  • Antitoxin therapy

  • Other agents

  • Supportive care

Inpatient care

Serial clinical assessment, neurologic deficits: as per CDC 2021 guidelines, obtain frequent, serial neurologic examinations with an emphasis on cranial nerve palsies, swallowing ability, respiratory status, and extremity strength. Conduct the serial neurologic and other examinations by the same healthcare provider, when possible.
Show 2 more

More topics in this section

  • Serial clinical assessment (respiratory compromise)

  • Serial clinical assessment (hemodynamic status)

  • Serial clinical assessment (other complications)

Specific circumstances

Pediatric patients
As per CDC 2021 guidelines:
Obtain close monitoring for worsening paralysis in pediatric patients with suspected foodborne botulism treated with botulinum antitoxin therapy according to the weight-based dose described in the package insert.
Consider administering retreatment in patients with a lack of response to the treatment when confidence in the diagnosis of botulism is substantial.

More topics in this section

  • Pregnant patients